back to company universe
AI infrastructure

WhiteLab Genomics

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

sources
1
Evidence entries preserved.
affiliations
1
Y Combinator
competitors
5
Mapped from High Signal graph features.
status
generated
D1 lookup
last updated
2026-07-15
16:41 UTC
source evidence
Why this company exists here

Y Combinator

yc-company-directory #4758

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

source
generated read
High Signal interpretation

WhiteLab Genomics is classified as AI infrastructure from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.

offline extraction
Product facets
Cell TherapiesRNA TherapiesDNA Therapiesgenomic therapiesAI platform
mapping method
Similarity graph

Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.

discovery cluster

Companies similar to WhiteLab Genomics

AI infrastructure · 5 peers

A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.

Humane Genomics

match 41

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading e

shared product terms: genomic, develop, design, therapie; shared affiliation: Y Combinator

Latent Space

match 28

Latent Space develops AI applications specifically designed to address the unique challenges and opportunities in emerging economies. Our products are Halo AI (an AI universal concierge for SEA enterprises), GoVisa (an AI-enabled online visa and permit application), and Supa (a hyperlocal knowledge AI for 280M+ Indonesians).

shared product terms: develop, enabl, design; same category: AI infrastructure; shared affiliation: Y Combinator

Coast

match 28

The first AI-powered demo platform designed to sell, market and implement technical products with ease. Our visual platform makes APIs more accessible and accelerates commercialization, enabling high-impact digital transformation for the world’s largest enterprises.

shared product terms: enabl, accelerate, design; same category: AI infrastructure; shared affiliation: Y Combinator

Forever Labs

match 25

Forever Labs collects and stores adult stem cells, and develops therapies based upon stem cell rejuvenation.

shared product terms: cell, develop, therapie; shared affiliation: Y Combinator

RatedPower

match 24

RatedPower developed pvDesign app, a SaaS to accelerate and optimize the design of Solar Photovoltaic plants worldwide.

shared product terms: develop, accelerate, design